journal of thrombosis and thrombolysis سال:2017 - دوره:43

Fa | Ar | En


journal of thrombosis and thrombolysis
سال:2017 - دوره:43 - شماره:4

appropriateness of direct oral anticoagulant dosing for venous thromboembolism treatment - صفحه:505-513 association between ck-mb area under the curve and tranexamic acid utilization in patients undergoing coronary artery bypass surgery - صفحه:446-453 decompressive surgery in malignant cerebral venous sinus thrombosis: what predicts its outcome? - صفحه:530-539 determination of non-vitamin k oral anticoagulant (noac) effects using a new-generation thrombelastography teg 6s system - صفحه:437-445 diabetes mellitus is associated with increased bleeding in pulmonary embolism receiving conventional anticoagulant therapy: findings from a “real-world” study - صفحه:540-549 effect of the fxa inhibitors rivaroxaban and apixaban on platelet activation in patients with atrial fibrillation - صفحه:490-497 effects of thromboprophylactic doses of apixaban and rivaroxaban on coagulation and thrombin generation in association with total hip replacement - صفحه:562-569 enoxaparin dose reduction for thrombocytopenia in patients with cancer: a quality assessment study - صفحه:514-518 etiology and complications of thrombocytopenia in hospitalized medical patients - صفحه:429-436 evaluating the safety and effectiveness of venous thromboembolism prophylaxis in patients with sickle cell disease - صفحه:463-468 evaluation of safety and effectiveness of standardized antifactor xa-based unfractionated heparin protocols in obese versus non-obese patients - صفحه:476-483 family history of venous thromboembolism and mortality after venous thromboembolism: a swedish population-based cohort study - صفحه:469-475 implications of an inpatient warfarin dosing nomogram on safety outcomes post-discharge - صفحه:454-462 intravenous thrombolysis for stroke after dabigatran reversal with idarucizumab: an update - صفحه:528-529 net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from re-cover®, re-cover™ ii, and re-medy™ - صفحه:484-489 oral antiplatelet drugs in patients with chronic kidney disease (ckd): a review - صفحه:519-527 prospective evaluation of a bivalirudin to warfarin transition nomogram - صفحه:498-504 reduced anticoagulation variability in patients on warfarin monitored with fiix-prothrombin time associates with reduced thromboembolism: the fiix-trial - صفحه:550-561